Last updated on August 2019

A Study of ASP2215 (Gilteritinib) by Itself ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy


Find a site near you

Start Over

Site ES34004

Barcelona, Spain
3.77miles
  Connect »

Site ES34010

Barcelona, Spain
5.81miles
  Connect »

Site ES34009

Barcelona, Spain
7.22miles
  Connect »

Site ES34008

Barcelona, Spain
7.37miles
  Connect »